Dermatosurgical devices market seen reaching $10.03 billion by 2030

The Business Research Company says the global dermatosurgical devices market will rise from $6.24 billion in 2025 to $10.03 billion by 2030, driven by skin disorders, cosmetic procedures and wider use of laser technologies. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through the forecast period.

Why it matters: - The dermatosurgical devices market is tied to rising demand for skin disease treatment and aesthetic procedures. - Growth in minimally invasive care, outpatient dermatology and precision-based devices could expand adoption across clinical and cosmetic settings. - The market’s projected climb to $10.03 billion by 2030 signals continued investment in dermatology technology.

What happened: - The Business Research Company released its Dermatosurgical Devices Global Market Report 2026, covering market size, trends and forecasts for 2026-2035. - The report says the market will grow from $6.24 billion in 2025 to $6.88 billion in 2026, a 10.3% CAGR. - The forecast calls for the market to reach $10.03 billion by 2030 at a 9.9% CAGR. - The report was dated Sept. 8, 2026 and published from London. - A free sample of the report is available here. - The full report is available here.

The details: - Dermatosurgical devices are specialized instruments used for surgical and cosmetic procedures involving skin, hair, nails and related tissues. - Uses include skin lesion removal, scar revision, laser resurfacing, hair restoration and treatment of skin disorders. - Growth drivers include more skin disorders, more cosmetic enhancements, more dermatology facilities, higher awareness of skin health and wider acceptance of laser technologies. - Additional growth factors include rising consumer demand for personalized dermatological care, more funding in aesthetic medicine, more minimally invasive procedures and more outpatient dermatology services. - Key trends include a preference for minimally invasive treatments, more cosmetic skin therapies, precision-based devices, scar treatment and skin rejuvenation. - The report says escalating skin disorders and skin cancers remain a major driver of demand. - Skin conditions named in the report include acne, eczema, psoriasis, pigmentation issues, melanoma and non-melanoma skin cancers. - The report links ultraviolet exposure from sunlight and artificial sources to higher risk of chronic and malignant skin conditions. - Dermatosurgical instruments are used in lesion excision, laser therapy, electrosurgery, cryotherapy and skin resurfacing. - A May 2026 JAMA Network projection said US melanoma disability-adjusted life years could rise from about 2 million in 2025 to more than 3.3 million by 2050. - North America held the largest share of the dermatosurgical devices market in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 report adds market attractiveness scoring, total addressable market analysis, company scoring matrices, Excel-based forecasting dashboards, market hotspot infographics, key technology analysis and updated graphics and tables.

Between the lines: - The forecast points to a market shaped by both medical need and elective demand. - The mix of cancer-related treatment needs and cosmetic use suggests the sector is less exposed to a single demand source than many medtech categories. - Faster growth in Asia-Pacific may reflect expanding access to dermatology services and aesthetic medicine across the region.

What's next: - The market will be watched for adoption of laser systems, minimally invasive techniques and outpatient workflows. - Future growth will likely track changes in skin disease prevalence, cosmetic treatment demand and investment in aesthetic medicine. - Regional competition may intensify as Asia-Pacific growth outpaces other markets.

The bottom line: - Dermatosurgical devices are moving from a niche clinical category to a broader growth market powered by medical treatment, cosmetic care and technology adoption.